Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = dysorgasmia

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
12 pages, 238 KB  
Review
Ejaculatory and Orgasmic Dysfunction Following Prostate Cancer Therapy: Clinical Management
by Travis P. Green, Jose Saavedra-Belaunde and Run Wang
Med. Sci. 2019, 7(12), 109; https://doi.org/10.3390/medsci7120109 - 10 Dec 2019
Cited by 11 | Viewed by 8907
Abstract
The majority of sexual health research has focused on erectile dysfunction following prostate cancer treatment. Ejaculatory and orgasmic dysfunction are significant side effects following the treatment of prostate cancer. Orgasmic dysfunction covers a range of issues including premature ejaculation, anorgasmia, dysorgasmia, and climacturia. [...] Read more.
The majority of sexual health research has focused on erectile dysfunction following prostate cancer treatment. Ejaculatory and orgasmic dysfunction are significant side effects following the treatment of prostate cancer. Orgasmic dysfunction covers a range of issues including premature ejaculation, anorgasmia, dysorgasmia, and climacturia. This review provides an overview of prevalence and management options to deal with orgasmic dysfunction. A Medline Pubmed search was used to identify articles relating to these problems. We found that orgasmic dysfunction has a very large impact on patients’ lives following prostate cancer treatment and there are ways for physicians to treat it. Management of patients’ sexual health should be focused not only on erectile dysfunction, but on orgasmic dysfunction as well in order to ensure a healthy sexual life for patients and their partners. Full article
(This article belongs to the Special Issue Men's Sexual Health)
Back to TopTop